Article Contents ::
- 1 Details About Generic Salt :: Levetira
- 2 Main Medicine Class:: Anticonvulsant
- 3 (lev-eh-TEER-ah-see-tam) Keppra Class: Anticonvulsant
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Levetira
Main Medicine Class:: Anticonvulsant
(lev-eh-TEER-ah-see-tam)
Keppra
Class: Anticonvulsant
Drugs Class ::
Action Mechanism unknown; may selectively prevent hypersynchronization of epileptiform burst firing and propagation of seizure activity.
Indications for Drugs ::
Indications Adjunctive therapy in partial onset seizures in adults with epilepsy.
Drug Dose ::
Route/Dosage
ADULTS: PO Initiate therapy with 500 mg bid; dose may be increased by 1000 mg daily every 2 weeks to a maximum daily dose of 3000 mg.
Contraindication ::
Contraindications Standard considerations.
Drug Precautions ::
Precautions
Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established in patients < 16 year of age. Impaired renal function: Should use reduced doses. Withdrawal seizures: Do not discontinue abruptly because of possible increased seizure frequency. Dialysis patients: Administer supplemental doses because drug is removed during the treatment.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
RESP: Cough; pharyngitis; rhinitis; sinusitis. CNS: Somnolence; dizziness; headache; amnesia; anxiety; ataxia; depression; emotional lability; hostility; nervousness; paresthesia; vertigo. EENT: Diplopia. GI: Anorexia. OTHER: Asthenia; infection; pain.
Drug Mode of Action ::
Action Mechanism unknown; may selectively prevent hypersynchronization of epileptiform burst firing and propagation of seizure activity.
Drug Interactions ::
Interactions None well documented.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies.
- Monitor patient for potential hypersensitivity.
- Monitor for signs and symptoms of asthenia, somnolence, and dizziness that might occur, especially in the first weeks of treatment.
- Monitor patient’s CBC and for signs and symptoms of infection.
- Monitor renal function.
- Exercise caution to assure that patients are withdrawn gradually from levetiracetam or any other antiseizure drug to avoid the potential of increased seizures.
|
Drug Storage/Management ::
Administration/Storage
- Store at room temperature. Excursions permitted to 15° to 30°C (59° to 86°F).
- Administer orally as adjunct therapy with or without food.
- Do not administer to pregnant women unless it is determined that the benefit to the mother justifies the potential risk to the fetus.
Drug Notes ::
Patient/Family Education
- Inform patient that levetiracetam does not cure the cause of seizure activity but will control symptoms.
- Caution patient to take the dose exactly as prescribed and not to stop taking the medication even if feeling better. Instruct patient not to increase or decrease the dosage.
- Teach family that seizure control requires rigid adherence to the prescribed regimen, as noncompliance is a major cause of therapeutic failure.
- Caution patient to stop taking levetiracetam or any other antiseizure medication abruptly; there is potential for increased seizure activity.
- Teach patient/family to maintain a seizure frequency chart indicating the date, time, and nature of all seizure events as prescriber can use this record to evaluate treatment, make dosage adjustments, and alter drug selections.
- Warn patient against using alcohol, antihistamines, and or other CNS depressants as these will intensify the depressant effects of antiseizure medications.
- Advise patient that levetiracetam may cause dizziness and somnolence.
- Instruct patient/family that if seizures occur, the patient should be protected from injury.
- Caution patient/family that patient should neither drive a car, operate complex machinery, or engage in any other hazardous activity until knowing the reaction to the drug.
- Advise patient to notify physician immediately if pregnant, planning to become pregnant, or planning to breastfeed.